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spirin, But Not Clopidogrel,
educes Collateral Conductance in a
abbit Model of Femoral Artery Occlusion
mo E. Hoefer, MD, PHD,*†‡ Sebastian Grundmann, MD,*† Stephan Schirmer, MD,*†
iels van Royen, MD, PHD,§ Benjamin Meder, MD,* Christoph Bode, MD,* Jan J. Piek, MD, PHD,§
vo R. Buschmann, MD*
reiburg and Berlin, Germany; and Utrecht and Amsterdam, the Netherlands
OBJECTIVES The objective of this study was to test the potential of aspirin and clopidogrel to influence
collateral artery growth (arteriogenesis).
BACKGROUND Aspirin and clopidogrel are antiplatelet agents commonly used in the treatment of ischemic
cardiovascular disease. Both inhibit platelet aggregation; however, they differ mechanistically
because aspirin acts via cyclooxygenase (COX) inhibition, while clopidogrel noncompetitively
antagonizes the P2Y12 adenosine diphosphate receptor. We hypothesized that aspirin, due to
its anti-inflammatory effects through inhibition of COX activity could inhibit arteriogenesis.
Given that clopidogrel does not affect COX activity, it would be less likely to interfere with
collateral artery growth.
METHODS Fifty-four New Zealand White rabbits received either saline, aspirin (10 mg/kg), or
clopidogrel (10 mg/kg) for seven days after femoral artery ligation. Maximal collateral
conductance was assessed with fluorescent microspheres under maximal vasodilation; cellular
migration and proliferation (Ki-67) was evaluated by quantitative immunohistology.
RESULTS Collateral conductance was significantly reduced by aspirin treatment, whereas clopidogrel
had a neutral effect (saline: 0.94  0.04; clopidogrel: 0.94  0.05; aspirin: 0.64  0.03
ml · min1 · 100 mm Hg1 · g1; p  0.001). Ki-67 proliferation indexes were consistent
with these results (saline: 23.1  2.9%; clopidogrel: 23.5  1.1%; aspirin: 19.2  1.1%
Ki-67–positive cells). Immunohistochemistry showed COX expression in collateral arteries
and a significantly decreased monocyte/macrophage accumulation in the perivascular tissue
after aspirin treatment. Cell adhesion molecule expression on monocytes after activation was
significantly reduced by aspirin, which might explain the reduced migratory ability.
CONCLUSIONS In summary, clopidogrel had a neutral effect on natural arteriogenesis. Aspirin significantly
inhibited collateral artery growth, probably due to its anti-inflammatory effect. Additional
studies are needed to substantiate these results before translation into clinical
practice. (J Am Coll Cardiol 2005;46:994–1001) © 2005 by the American College of
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.02.094Cardiology Foundation
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ds a natural compensation mechanism upon arterial occlu-
ion, a preexisting network of collateral anastomoses is
ecruited and develops into functional collateral arteries.
his process is referred to as arteriogenesis and provides the
schemic territory with nutrient blood flow (1). A decisive
tep in arteriogenesis is the increase in the pressure gradient
long the arteriolar anastomoses (prestenotic minus postste-
otic pressure), once a stenosis in the main feeding artery
ecomes hemodynamically relevant. The increase in net
orward blood flow leads to increased shear forces acting on
he endothelium of collateral arteries. This sustained in-
rease in shear stress within newly recruited collateral
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yers-Squibb Germany.c
Manuscript received August 4, 2004; revised manuscript received January 20, 2005,
ccepted February 14, 2005.rteries leads to expression and presentation of cell adhesion
olecules (e.g., intracellular adhesion molecule-1, vascular
ell adhesion molecule-1) (2) and up-regulation of chemo-
ines and colony stimulating factors by the endothelium.
he secreted cytokines attract monocytes, which then ad-
ere to endothelial cell adhesion molecules, transmigrate,
nd accumulate in the perivascular tissue of proliferating
ollateral arteries (3,4). After infiltration, the monocytes
ature to macrophages, producing numerous cytokines and
egrading enzymes, thereby creating the controlled inflam-
ation necessary to remodel an arteriole into an artery (3,5).
his scenario is in large part similar to the processes
ccurring during inflammation, and the factors involved are
ften identical (6,7).
Compounds inhibiting platelet aggregation (e.g., aspirin,
lopidogrel) have been shown to successfully reduce cardio-
ascular mortality in patients suffering from coronary heart
isease (8). In particular, aspirin has been shown to improve
linical outcome in numerous studies. Aspirin belongs to the
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September 20, 2005:994–1001 Platelet Inhibition and Collateral Artery Growthroup of non-steroidal anti-inflammatory drugs (NSAIDs)
hat have been shown to inhibit leukocyte accumulation
uring inflammatory diseases (9–11). Although the mech-
nism of this anti-inflammatory action is not completely
nderstood, inhibition of the cyclooxygenases (COX) has
een proven to be crucial. Aspirin is a potent irreversible
nhibitor of both COX-1 and COX-2. In addition to its
nhibitory effect on leukocyte migration (12–14), it further
nhibits subsequent leukocyte activation (15). In contrast,
lopidogrel acts as a noncompetitive antagonist of the P2Y12
denosine diphosphate (ADP) receptor on platelets and
oes not display comparable anti-inflammatory properties.
Because arteriogenesis depends on monocyte migration
nd activation, we hypothesized that treatment with aspirin
otentially attenuates arteriogenesis after arterial occlusion,
hereas clopidogrel might not.
ETHODS
his study was performed after securing appropriate insti-
utional approvals. It conforms to the Guide for the Care
nd Use of Laboratory Animals (National Institutes of
ealth Publication No. 85-23, revised 1996). After ligation
f the right femoral artery as previously described (16), 54
ew Zealand White rabbits of comparable weight (3.0 
.2 kg) and age were randomly assigned to one of three
roups (n  18 each). Assignment to the groups was done
y an observer blinded to the purpose and the treatment
ptions of the study. Group 1 consisted of animals receiving
ormal saline orally, whereas animals of group 2 received
lopidogrel (obtained from Bristol-Myers-Squibb, Munich,
ermany) per os once daily in a dose of 10 mg/kg body
eight via gavage). Group 3 received aspirin (acetylic
alicylic acid) 10 mg/kg body weight/day analogous to group
. These doses have been shown to effectively inhibit
latelet aggregation to a comparable degree in the rabbit in
revious studies (17–19). No animal suffered gangrene,
ecrosis, or gross impairment of hind limb function after the
nitial operation. There was no observable difference in
ostoperative behavior or body weight between any groups
t any time point.
During the observation period, blood samples were with-
rawn from six animals per group for assessment of leuko-
yte activation. Seven days after femoral artery ligation, the
nimals were again anesthetized for either postmortem
ngiography (n  6 each), hemodynamic measurements (n 
Abbreviations and Acronyms
ADP  adenosine diphosphate
COX  cyclooxygenase
Mac-1  membrane attack complex-1
LPS  lipopolysaccharide
LFA-1  leukocyte functional antigen-1
MCP  monocyte chemoattractant protein
NSAID  non-steroidal anti-inflammatory drugeach), or preparation of histological samples (n  6 each). cata collection and analysis was performed by an observer
linded to the group assignment until completion of the
tudy.
ostmortem angiograms. After maximal vasodilatation
ith adenosine, legs were perfused with PBS in a warmed
aterbath (37°C) for 1 min at 80 mm Hg followed by
erfusion for 8 min at 80 mm Hg with contrast medium
ased on bismuth and gelatin (20). Subsequently, the
ontrast medium was allowed to gel by placing the limbs on
rushed ice for 45 min.
Collateral arteries were classified according to Longland
21) into stem, midzone, and reentry. Collateral vessels were
arked after counting to be certain that no vessel was
ounted twice.
emodynamic measurements. Collateral conductance
easurements were performed as previously described (16).
pump-driven shunt between the left carotid artery and
bdominal aorta was installed by cannulating both vessels.
o ensure proper mixing of the microspheres with the
erfusate, a mixing chamber was serially installed into the
hunt system. Prestenotic blood pressure was measured at
he place of the aortic cannula insertion. Poststenotic blood
ressure was measured by cannulating the saphenous artery
ust above the ankle. The left femoral artery was cannulated
or withdrawal of blood flow reference samples for subse-
uent calculation of the specific blood flows to each tissue
ample. This resulted in an acute occlusion of the left
emoral artery, and perfusion data of the left hind limb was
herefore used as an internal control, ensuring comparability
f the obtained data. Using a roller-pump, six different
ressure levels were maintained under continuous flow and
ressure monitoring. Maximal vasodilation was achieved by
ontinuous adenosine infusion into the shunt system (1
g/kg/min). At each pressure level, fluorescent micro-
pheres (Molecular Probes, Leiden, the Netherlands) with a
ifferent label (in order of injection: scarlet, crimson, red,
lue-green, orange, and yellow-green, 2 · 106 each) were
njected.
Tissue samples for the evaluation of collateral-dependent
ow were harvested after weighing the muscles they were
erived from and then weighed and further processed for
ow cytometric quantification of microspheres per sample.
low to each tissue sample was then calculated from the
umber of microspheres in the samples and the respective
mount of microspheres in the reference sample. Based on
he weight of the tissue samples, perfusion was expressed as
l/min/g tissue. For a better comparison with other studies,
he total tissue mass depending on collateral perfusion was
eighed and multiplied with the perfusion values per gram,
hich thus indicates the total conductance of the collateral
etwork. The resulting collateral blood flows were plotted
gainst their respective pressure levels (pressure gradient of
restenotic minus poststenotic pressure). Collateral conduc-
ance equals the slope of the resulting curve of the six
ifferent pressure-flow relations and reflects the change in
ollateral flow per increase of the pressure gradient. Slope
w
0
L
i
g
t
f
K
i
m
a
w
t
S
c
p
o
a
s
s
t
e
H
z
a
p
C
l
i
b
e
o
O
t
m
n
l
s
R
g
n
w
a
A
m
a
w
m
s
m
f
g
o
t
t
p
S
A
g
C
p
a
R
P
f
r
p
t
d
a
s
c
H
s
a
f
m
0
0
t
t
p
(
s
0
s
d
L
b
c
(
t
t
(
c
t
m
m
a
m
1
p
d
(
0
s
0
996 Hoefer et al. JACC Vol. 46, No. 6, 2005
Platelet Inhibition and Collateral Artery Growth September 20, 2005:994–1001as calculated by least squares with R2 values of 0.89 
.01.
eukocyte activation testing. At day 1, 3, and 5 after the
nitial operation, blood was withdrawn from animals of each
roup in heparin-coated tubes to analyze leukocyte activa-
ion. Directly after the withdrawal, whole blood was stained
or CD11a, CD11b, and CD18 (all Serotec, Oxford, United
ingdom) using specific mouse anti-rabbit antibodies. For
dentification of monocytes, blood samples were further-
ore stained with a phycoerythrin-conjugated anti-CD14
ntibody (DAKO, Glastrup, Denmark). The blood samples
ere then divided into three smaller samples, from which
he first one was left untreated and served as the control.
amples two and three were stimulated with lipopolysac-
haride (LPS) (200 ng/ml) and monocyte chemoattractant
rotein (MCP)-1 (200 ng/ml), respectively. After addition
f the factors, samples were incubated at 37°C in a 5% CO2
tmosphere for 2 h. Subsequent to the incubation period,
amples were stained as described above for examination of
urface molecule expression. The influence of the previous
reatment on the activation potency of leukocytes was
xpressed as the ratio of stimulated to nonstimulated blood.
istological examinations of in vivo cell migration. Fro-
en tissue sections (5 m) were stained for Ki-67 (mouse
nti-rat Ki-67, Clone MIB-5, DAKO) to quantify the
roliferative index of vascular smooth muscle cells (Sigma
hemical Company, St. Louis, Missouri) and the endothe-
ium. Thirty sections in 400-m intervals from the vastus
ntermedius quadriceps per animal were analyzed by a
linded observer under 400-fold magnification. The prolif-
rative index of each vessel was calculated as the percentage
f Ki-67–positive cells within the growing collateral arteries.
nly growing collateral arteries are positively marked for
he proliferation marker Ki-67, whereas vascular smooth
uscle cells from quiescent “normal” arteries remain
egative.
To examine and quantify the number of transmigrated
eukocytes, tissue sections were performed as above and
tained with a mouse anti-rabbit CD11b (Mouse anti-
abbit CD11b, Clone 198, Serotec) antibody, staining
ranulocytes and monocytes/macrophages. Only cells defi-
itely showing a positive stain and an identifiable nucleus
ere counted in one microscopic field around the collateral
rtery at 200-fold magnification by a blinded observer.
dditionally, monocytes/macrophages were stained with a
ouse anti-human CD68 antibody (Monoclonal Mouse
nti-Human CD68, Macrophage, Clone EBM11, DAKO),
hich has been shown to cross-react with rabbit monocytes/
acrophages previously. Again, only cells with positive
taining around a nucleus were identified and counted as
acrophages. Numbers were expressed per mm2, calculated
rom the area of the microscopic field.
Expression of COX-1 was assessed by staining with a
oat anti-human COX-1 antibody (Santa Cruz Biotechnol-
gy, Inc., Santa Cruz, California) recognizing the carboxy
erminus of COX-1. Double staining for CD11b as men- aioned above was performed to identify the identity of
erivascular COX-1–positive cells.
tatistical analysis. Results are expressed as mean SEM.
ll statistical analyses between treatment groups and control
roup were performed with SigmaStat software (SPSS Inc.,
hicago, Illinois) using one-way analysis of variance and
ost-hoc Bonferroni correction (n 3 comparisons for each
nalysis).
ESULTS
ostmortem angiograms. Postmortem angiograms per-
ormed after seven days showed numerous collateral arteries
unning from the arteria circumflexa femoris and the arteria
rofunda femoris, thereby bypassing the stenosis caused by
he ligation of the femoral artery. There was no significant
ifference between any of the groups, as the number of
ngiographically detectable collateral arteries was not mea-
urably altered by any treatment regimen (saline: 16.7 1.2;
lopidogrel: 17.3  1.2; aspirin: 16.2  2.0) (Fig. 1).
emodynamic measurements. Collateral conductance
even days after ligation of the right femoral artery showed
5-fold increase as compared to acute occlusion of the left
emoral artery. Daily oral administration of clopidogrel at 10
g/kg did not affect collateral conductance (saline: 0.94 
.04 ml · min1 · 100 mm Hg1 · g1, clopidogrel: 0.94 
.05 ml · min1 · 100 mm Hg1 · g1; p  NS). In con-
rast, oral treatment with aspirin using the same dosage led
o a significant reduction in collateral conductance com-
ared to untreated as well as to clopidogrel-treated animals
aspirin: 0.64  0.03 ml · min1 · 100 mm Hg1 · g1;
aline vs. aspirin p  0.001; clopidogrel vs. aspirin p 
.001). Furthermore, to allow better comparisons with other
tudies, collateral conductance for the total tissue mass
epending on collateralization was calculated (Fig. 2).
eukocyte activation. Immediately after withdrawal of the
lood samples, no significant difference in membrane attack
omplex-1 (Mac-1) and leukocyte functional antigen-1
LFA-1) expression on monocytes and granulocytes was de-
ected between untreated, aspirin-treated, and clopidogrel-
reated animals. However, the relative increase of Mac-1
CD11b) and LFA-1 (CD11a) expression as markers of
ellular activation was significantly reduced by prior aspirin
reatment as compared to leukocytes from untreated ani-
als. This observation remained constant during the treat-
ent period. In contrast to the findings in aspirin-treated
nimals, clopidogrel treatment did not affect the efficacy of
onocyte activation by MCP-1 (CD11a expression: saline:
.27  0.02; clopidogrel: 1.31  0.04; aspirin: 1.18  0.03;
 0.05) (CD11b expression: saline: 1.26  0.04; clopi-
ogrel: 1.29 0.03; aspirin: 1.22 0.03, pNS) and LPS
CD11a expression: saline: 1.38 0.04; clopidogrel: 1.39
.03; aspirin: 1.15  0.03; p  0.05) (CD11b expression:
aline: 1.50  0.03; clopidogrel: 1.42  0.03; aspirin: 1.36 
.04; p 0.05 for aspirin vs. saline; pNS for clopidogrel vs.
spirin).
H
l
C
m
m
C
u
c
p
c
m
F Neith
n
F
b

s
997JACC Vol. 46, No. 6, 2005 Hoefer et al.
September 20, 2005:994–1001 Platelet Inhibition and Collateral Artery Growthistological examination of in vivo cell migration. Pro-
iferating collateral arteries showed positive staining for
OX-1 in the endothelium and a higher expression in
igrated cells. Double staining for CD11b identified trans-
igrated leukocytes as the source of the perivascular
OX-1 expression (Fig. 3A). In normal arterial vessels not
igure 1. Postmortem angiograms one week after femoral artery ligation.
umber of collateral arteries.
igure 2. Collateral conductance measurements for the total tissue mass tha
ars). Aspirin treatment significantly reduced collateral conductance, wher1.9 ml/min/100 mm Hg; clopidogrel: 49.5  2.4 ml/min/100 mm Hg; aspiri
ubjected to acute occlusion of the femoral artery served as an internal controlndergoing proliferation in the control hind limb, COX-1
ould only be found in endothelial cells.
Quantitative assessment of leukocyte migration into the
erivascular space of the growing collateral arteries showed
omparable numbers of CD68-positive monocytes/
acrophages in untreated and clopidogrel-treated animals.
er aspirin nor clopidogrel treatment affected angiographic appearance and
nds on the collateral network seven days after femoral artery ligation (open
opidogrel treatment did not functionally affect arteriogenesis (saline: 50.7t depe
eas cln: 32.6  1.6 ml/min/100 mm Hg). The contralateral hind limb that was
(solid bars).
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Platelet Inhibition and Collateral Artery Growth September 20, 2005:994–1001he number of transmigrated monocytes/macrophages in
spirin-treated animals was significantly reduced compared
o the other groups (saline: 27.0  3.3; clopidogrel: 22.9 
.3; aspirin: 17.5  0.4 CD68-positive cells mm2) (Fig. 3B,
eft column). Comparable results were obtained for the
uantity of CD11b-positive leukocytes (monocytes/
acrophages and granulocytes). While clopidogrel treat-
ent did not affect accumulation of CD11b-positive cells,
reatment with aspirin significantly reduced leukocyte mi-
ration (saline: 33.1  2.3; clopidogrel: 29.6  1.9; aspirin:
8.5  1.3 CD11b-positive cells/mm2) (Fig. 3B, middle
olumn).
roliferation indexes. Ki-67 staining showed growth and
roliferation of arteriolar anastomoses to functional collat-
ral arteries, whereas “normal” muscle feeding vessels re-
ained negative. Aspirin treatment significantly reduced
he proliferation index (Ki-67–positive cells vs. total number
f cells) in the media of collateral vessels as compared to the
igure 3. (A) Staining for cyclooxygenase (COX)-1 (red) indicated expr
roliferating collateral arteries, transmigrated CD11b-positive leukocytes (
B) Immunohistological staining for vascular smooth muscle cells (green) a
roliferating collateral arteries (first two columns). Proliferating cells (thir
f the growing vessels. Vascular smooth muscle cells are stained green and
nd proliferation; clopidogrel-treated animals showed comparable results aontrol and the clopidogrel group (saline: 23.1  1.2%; clopidogrel: 23.5  0.4%; aspirin: 19.2  0.5% Ki-67–
ositive vascular smooth muscle cells) (Fig. 3B). In concor-
ance with previous reports (22), this correlated well with
roliferation of the endothelium in these vessels (saline:
9.4  0.4%; clopidogrel: 19.6  0.4%; aspirin: 17.6 
.3% Ki-67–positive endothelial cells).
ISCUSSION
schemic events affecting the cerebral, coronary, and periph-
ral arteries are different manifestations of a common
athophysiological process, namely atherothrombosis, or
hrombus formation superimposed on preexisting athero-
clerotic plaque (23). Aspirin is thought to prevent throm-
otic vascular occlusion by inhibiting platelet aggregation,
nd is widely prescribed for this purpose. More recently,
ovel compounds (e.g., clopidogrel) have been developed to
nhibit platelet aggregation, although by different pharma-
in the endothelium of quiescent arteries in the control hind limb. In
) reveal a strong positive stain and serve as additional sources of COX-1.
cumulating monocytes/macrophages (red) in the surrounding tissue of the
mn) stained for the Ki-67 antigen (red) are mainly localized in the media
i appear blue. Aspirin treatment significantly reduced leukocyte migration
ne-treated animals.ession
green
nd ac
d coluodynamic mechanisms. Aspirin irreversibly and unselec-
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September 20, 2005:994–1001 Platelet Inhibition and Collateral Artery Growthively blocks COX-1 and -2, whereas clopidogrel (i.e., its
ctive metabolite) acts as a noncompetitive antagonist of the
2Y12 ADP receptor on platelets. Because platelet inhibi-
ors have become the standard medications for the treat-
ent of patients with cardiovascular diseases, this study
ocused on the role of aspirin and clopidogrel on collateral
rtery growth (arteriogenesis). Our hypothesis was further
upported by the observation of the Clopidogrel Versus
spirin in Patients at Risk of Ischaemic Events (CAPRIE)
nvestigators, who described a relative risk reduction for
troke, myocardial infarction, and death due to vascular
auses of 8.7% with clopidogrel compared to aspirin in more
han 19,000 patients with recent symptomatic atheroscle-
otic disease (24,25).
Nonsteroidal anti-inflammatory drugs and their effect on
essel growth, in particular their influence on angiogenesis
i.e., formation of new capillary networks) have been the
ubject of numerous studies. Although recent studies
howed comparable antiangiogenic properties of aspirin and
ther NSAIDs in different models, the underlying mecha-
isms have not yet been clarified (26–29). However, arte-
iogenesis differs from angiogenesis: collateral vessels are
reexisting rather than newly built vessels (30), and their
rowth is not dependent on ischemia (4,31), but is mainly
nduced by increased hemodynamic shear forces.
To the best of our knowledge, this is the first study to
eport an inhibitory effect of aspirin on arteriogenesis. The
abbit hind limb model is well-established and widely used
o examine collateral artery growth in the peripheral circu-
ation and offers the possibility of hemodynamic measure-
ents with fluorescent microspheres. Moreover, the latter
onstitutes the “gold standard” in measuring tissue perfusion
32). Compared to other means of assessing vascular growth
rocesses (e.g., blood flow at rest) this method has been
hown to be more accurate in measuring collateral artery
rowth recently (22).
In our study collateral conductance (as the functional
arameter of collateral artery growth) was significantly
ecreased by daily oral administration of aspirin. Compared
o placebo-treated control animals, conductance was re-
uced by 40%. Quantitative immunohistochemistry for
ascular proliferation (Ki-67) provided additional evidence,
ecause aspirin-treated animals showed significantly lower
umbers of Ki-67–positive cells in the growing collateral
essels. The significant reduction in perfusion could not be
educted from postmortem angiograms. Due to the law of
agen-Poiseuille, very small changes in vessel diameter
esult in high changes in blood flow; therefore collateral
essel density in angiograms does not necessarily correlate
ith collateral flow. Furthermore, previous studies have
hown that angiographic scoring does not reflect tissue
erfusion as assessed by microsphere techniques (33). The
bserved differences in conductance (40%) reflect diame-
er changes of 10%, which are impossible to detect using
he angiographic techniques employed in this study. There-
ore, unlike previous studies with proarteriogenic com- eounds, no differences between treatment groups could be
etected by quantification of postmortem angiographies. To
etect these minor changes in diameter, more advanced but
imited available imaging methods are needed. Another
xplanation for the observed change in collateral flow might
e that the vasodilatory response is affected by the treat-
ent. This was ruled out by simultaneously measuring
ollateral conductance of the contralateral hind limbs that
nderwent an acute occlusion at the time of perfusion
easurement, which showed no significant differences be-
ween the groups (Fig. 2). The dose of adenosine has been
hown to ensure complete vasodilation in the rabbit hind
imb in different studies, abolishing any further vasodilatory
esponse (e.g., upon reactive hyperemia). Furthermore,
denosine was evaluated versus other vasodilatory com-
ounds (e.g., papaverine) (data not shown).
Staining for COX-1 in proliferating collateral arteries
dentified transmigrated, CD11b-positive leukocytes as the
ajor source of COX-1 apart from the endothelium, which
lso exhibited low COX-1 expression in normal arteries not
ndergoing proliferation. This is consistent with data from
therosclerotic patients colocalizing COX expression with
acrophages (34).
As previously described, monocytes/macrophages are the
ey mediators of arteriogenesis, in particular during early
tages (2). In aspirin-treated rabbits, the number of CD68-
ositive macrophages in the adventitial tissue was signifi-
antly reduced. As described above, the mechanisms under-
ying arteriogenesis are to a large extent similar to
echanisms responsible for inflammatory processes. Previ-
us studies have shown that aspirin significantly inhibits
eukocyte/monocyte adhesion to endothelium (35–37) and
ransendothelial migration (15,38), the first mandatory steps
f the arteriogenic response in early phases.
Monocyte transmigration is mediated by different cell
dhesion molecules. Leukocytes (e.g., monocytes) attach via
nteraction of the heterodimers CD18/CD11b (Mac-1) and
D18/CD11a (LFA-1) with intercellular adhesion
olecule-1 on the endothelium (39). Mac-1 is recognized as
n early marker of monocyte activation and is up-regulated by
ifferent activating factors (e.g., LPS, MCP-1). We therefore
ested whether monocytes from aspirin-treated animals
how an activation response to LPS and MCP-1 compara-
le to monocytes from untreated or clopidogrel-treated
nimals. The increase in CD11b expression after in vitro
timulation of aspirin-treated monocytes was significantly
ower than the activation potential of untreated monocytes.
his might explain the decreased numbers of migrated
onocytes/macrophages after aspirin treatment. As a po-
ential consequence, the deficit in growth factors released by
acrophages leads to reduced proliferation and a reduced
unctionality of the collateral network (i.e., a significant
nhibition and deceleration of arteriogenesis).
From the clinical point of view, it is reasonable to
peculate that a potential reduction of adaptive arteriogen-
sis with aspirin treatment might have a deleterious effect in
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Platelet Inhibition and Collateral Artery Growth September 20, 2005:994–1001he setting of ischemic cardiovascular disease, compared to
ther compounds with equal antithrombotic activity, but
ithout this unwanted side effect.
tudy limitations. The results of this study are based on
oses of aspirin and clopidogrel higher than those given in
linical practice. This might partially explain the prominent
ffect of aspirin treatment. Furthermore, we have not tested
he antiplatelet properties of the substances during our
xperiments. Due to the different mechanisms of action, a
irect comparison of the antiplatelet effect of clopidogrel
nd aspirin in the rabbit is not possible and requires different
nducers (e.g., ADP, arachidonic acid) of platelet aggrega-
ion. However, the used doses have been proven previously
o be of comparable efficacy regarding inhibition of platelet
ggregation in rabbits (19).
onclusions. In summary, this is the first study demon-
trating a direct inhibitory effect of aspirin on collateral
rtery growth. Clopidogrel, acting via mechanisms different
han COX inhibition, did not affect the natural arteriogenic
esponse. The possible clinical relevance of this observation
ill be tested prospectively in the ongoing ARTeriogenesis
ETwork (ART.NET)-1 trial. In this multicenter study,
he effects of physical training, aspirin, or clopidogrel on the
alking capacity of patients with stage II peripheral arterial
isease will be evaluated (n  125 patients/group).
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